It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Gladstone Institutes, Center for Systems and Therapeutics & Taube/Koret Center for Neurodegenerative Disease, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110); Taube-Koret Center for Neurodegenerative Disease, San Francisco, USA (GRID:grid.497581.6); Yumanity Therapeutics, Cambridge, USA (GRID:grid.511468.f) (ISNI:0000 0004 4911 3671)
2 Gladstone Institutes, Center for Systems and Therapeutics & Taube/Koret Center for Neurodegenerative Disease, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110)
3 University of Leicester, Department of Genetics and Genome Biology, College of Life Sciences, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411); DKFZ, Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584)
4 University of Leicester, Department of Genetics and Genome Biology, College of Life Sciences, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411)
5 University of California—San Francisco, Graduate Program in Chemistry and Chemical Biology, Department of Pharmaceutical Chemistry, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
6 Gladstone Institutes, Center for Systems and Therapeutics & Taube/Koret Center for Neurodegenerative Disease, San Francisco, USA (GRID:grid.249878.8) (ISNI:0000 0004 0572 7110); Taube-Koret Center for Neurodegenerative Disease, San Francisco, USA (GRID:grid.497581.6); University of California—San Francisco, Graduate Program in Biomedical Sciences, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California—San Francisco, Graduate Program in Neuroscience, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California—San Francisco, Graduate Program in Medical Scientist Training Program, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811); University of California—San Francisco, Department of Neurology and Physiology, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)